Embrex (NASDAQ:EMBX)
Historical Stock Chart
From Dec 2019 to Dec 2024
Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX)
announced Embrex management intends to file its Third Quarter 2005
Form 10-Q and issue its financial press release on Tuesday, November
1, 2005. Embrex's management, led by President and CEO Randall L.
Marcuson, will further discuss these financial results in a conference
call on Wednesday, November 2, at 11:00 a.m. EST. To join the
conference call, dial (877) 866-3175 (domestic and Canada), or (706)
679-7358 (international), identify Randall Marcuson as the conference
leader.
This call is being web cast by Thomson/CCBN and can be accessed at
Embrex's web site at www.embrex.com. Click on the Investor Info button
to access the link. The web cast is also being distributed over
Thomson/CCBN's Investor Distribution Network to both institutional and
individual investors. Individual investors can listen to the call
through Thomson/CCBN's individual investor center at www.earnings.com
or by visiting any of the investor sites in Thomson/CCBN's Individual
Investor Network. Institutional investors can access the call via
Thomson/CCBN's password-protected event management site, StreetEvents
(www.streetevents.com).
A telephone replay will be available from approximately 2 p.m. EST
November 2 to midnight EST November 16 by dialing (800) 642-1687
(domestic and Canada), or (706) 645-9291 (international), conference
ID #1699584.
Embrex, Inc., The In Ovo Company(R), is an international
agricultural biotechnology company engaged in the development of
innovative in ovo (in the egg) solutions that meet the needs of
today's global poultry industry.
Embrex(R) and The In Ovo Company(R) are trademarks of Embrex, Inc.